Treatment Options for Ovarian Low Malignant Potential Tumors
Early Stage Ovarian Low Malignant Potential Tumors (Stage
I and II)
Late Stage Ovarian Low Malignant Potential Tumors (Stage
III and IV)
Recurrent Ovarian Low Malignant Potential
Tumors
A link to a list of current clinical trials is included for each treatment section. For some stages, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Early Stage Ovarian Low Malignant Potential Tumors (Stage
I and II)
Surgery is the standard treatment for early stage ovarian low
malignant potential
tumor. The type of surgery usually depends on
whether a woman plans to have children.
For women who plan to have children, surgery is either:
To prevent recurrence of
disease, most doctors recommend surgery to remove the remaining ovarian tissue when a woman no longer plans to have children.
For women who do not plan to have children, treatment may
be hysterectomy and bilateral salpingo-oophorectomy.
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I borderline ovarian surface epithelial-stromal tumor 1 and stage II borderline ovarian surface epithelial-stromal tumor 2. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 3.
Late Stage Ovarian Low Malignant Potential Tumors (Stage
III and IV)
Treatment for late stage ovarian low
malignant potential
tumor may
be hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. A lymph node dissection may also be
performed.
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III borderline ovarian surface epithelial-stromal tumor 4 and stage IV borderline ovarian surface epithelial-stromal tumor 5. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 3.
Recurrent Ovarian Low Malignant Potential
Tumors
Treatment for recurrent ovarian low
malignant potential
tumor may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent borderline ovarian surface epithelial-stromal tumor 6. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 3.
|